BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 34406822)

  • 21. Self-reported cognitive functioning in postmenopausal breast cancer patients before and during endocrine treatment: findings from the neuropsychological TEAM side-study.
    Schilder CM; Seynaeve C; Linn SC; Boogerd W; Beex LV; Gundy CM; Nortier JW; van de Velde CJ; van Dam FS; Schagen SB
    Psychooncology; 2012 May; 21(5):479-87. PubMed ID: 21351188
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Meta-analysis of cognitive functioning in breast cancer survivors previously treated with standard-dose chemotherapy.
    Jim HS; Phillips KM; Chait S; Faul LA; Popa MA; Lee YH; Hussin MG; Jacobsen PB; Small BJ
    J Clin Oncol; 2012 Oct; 30(29):3578-87. PubMed ID: 22927526
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Trajectories of self-reported cognitive function in postmenopausal women during adjuvant systemic therapy for breast cancer.
    Merriman JD; Sereika SM; Brufsky AM; McAuliffe PF; McGuire KP; Myers JS; Phillips ML; Ryan CM; Gentry AL; Jones LD; Bender CM
    Psychooncology; 2017 Jan; 26(1):44-52. PubMed ID: 26486371
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Evaluation of plasma brain-derived neurotrophic factor levels and self-perceived cognitive impairment post-chemotherapy: a longitudinal study.
    Ng T; Lee YY; Chae JW; Yeo AHL; Shwe M; Gan YX; Ng RCH; Chu PPY; Khor CC; Ho HK; Chan A
    BMC Cancer; 2017 Dec; 17(1):867. PubMed ID: 29258453
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Relationship between exercise behavior, cardiorespiratory fitness, and cognitive function in early breast cancer patients treated with doxorubicin-containing chemotherapy: a pilot study.
    Crowgey T; Peters KB; Hornsby WE; Lane A; McSherry F; Herndon JE; West MJ; Williams CL; Jones LW
    Appl Physiol Nutr Metab; 2014 Jun; 39(6):724-9. PubMed ID: 24869976
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Verbal fluency in breast cancer patients treated with chemotherapy.
    Andryszak P; Wiłkość M; Żurawski B; Izdebski P
    Breast Cancer; 2017 May; 24(3):376-383. PubMed ID: 27435227
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Impact of Adjuvant Anthracycline-Based and Taxane-Based Chemotherapy on Plasma VEGF Levels and Cognitive Function in Breast Cancer Patients: A Longitudinal Study.
    Ng T; Phey XY; Yeo HL; Shwe M; Gan YX; Ng R; Ho HK; Chan A
    Clin Breast Cancer; 2018 Oct; 18(5):e927-e937. PubMed ID: 29705024
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cognitive impairment following chemotherapy for breast cancer: The impact of practice effect on results.
    Cerulla N; Arcusa À; Navarro JB; de la Osa N; Garolera M; Enero C; Chico G; Fernández-Morales L
    J Clin Exp Neuropsychol; 2019 Apr; 41(3):290-299. PubMed ID: 30477390
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cognitive functioning and quality of life following chemotherapy in pre- and peri-menopausal women with breast cancer.
    Klemp JR; Myers JS; Fabian CJ; Kimler BF; Khan QJ; Sereika SM; Stanton AL
    Support Care Cancer; 2018 Feb; 26(2):575-583. PubMed ID: 28849337
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Recovery from chemotherapy-induced white matter changes in young breast cancer survivors?
    Billiet T; Emsell L; Vandenbulcke M; Peeters R; Christiaens D; Leemans A; Van Hecke W; Smeets A; Amant F; Sunaert S; Deprez S
    Brain Imaging Behav; 2018 Feb; 12(1):64-77. PubMed ID: 28102529
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Neuropsychological functioning among patients with different types of cancer : Postchemotherapy cognitive impairment and implications for rehabilitation.
    Megari K
    Neuropsychiatr; 2021 Jun; 35(2):92-97. PubMed ID: 32274652
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cancer treatment effects on cognition and depression: The moderating role of physical activity.
    Bedillion MF; Ansell EB; Thomas GA
    Breast; 2019 Apr; 44():73-80. PubMed ID: 30685529
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Continuous, objective measurement of physical activity during chemotherapy for breast cancer: the Activity in Treatment pilot study.
    Nelson SH; Weiner LS; Natarajan L; Parker BA; Patterson RE; Hartman SJ
    Transl Behav Med; 2020 Oct; 10(4):1031-1038. PubMed ID: 31141593
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The effect of chemotherapy on subjective cognitive function in younger early-stage breast cancer survivors treated with chemotherapy compared to older patients.
    Gregorowitsch ML; Ghedri A; Young-Afat DA; Bijlsma R; Baas IO; van Schaik-van de Mheen C; Agterof MJ; Göker E; Ten Bokkel Huinink D; van den Bongard HJGD; Verkooijen HM;
    Breast Cancer Res Treat; 2019 Jun; 175(2):429-441. PubMed ID: 30746636
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Emerging From the Haze: A Multicenter, Controlled Pilot Study of a Multidimensional, Psychoeducation-Based Cognitive Rehabilitation Intervention for Breast Cancer Survivors Delivered With Telehealth Conferencing.
    Myers JS; Cook-Wiens G; Baynes R; Jo MY; Bailey C; Krigel S; Klemp J; Asher A
    Arch Phys Med Rehabil; 2020 Jun; 101(6):948-959. PubMed ID: 32179067
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effects of Baduanjin exercise on cognitive function and cancer-related symptoms in women with breast cancer receiving chemotherapy: a randomized controlled trial.
    Wei X; Yuan R; Yang J; Zheng W; Jin Y; Wang M; Jiang J; Wu C; Li K
    Support Care Cancer; 2022 Jul; 30(7):6079-6091. PubMed ID: 35416502
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The relationship of cognitive performance to concurrent symptoms, cancer- and cancer-treatment-related variables in women with early-stage breast cancer: a 2-year longitudinal study.
    Lyon DE; Cohen R; Chen H; Kelly DL; Starkweather A; Ahn HC; Jackson-Cook CK
    J Cancer Res Clin Oncol; 2016 Jul; 142(7):1461-74. PubMed ID: 27102492
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Longitudinal assessment of cognitive changes associated with adjuvant treatment for breast cancer: impact of age and cognitive reserve.
    Ahles TA; Saykin AJ; McDonald BC; Li Y; Furstenberg CT; Hanscom BS; Mulrooney TJ; Schwartz GN; Kaufman PA
    J Clin Oncol; 2010 Oct; 28(29):4434-40. PubMed ID: 20837957
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Clinical factors associated with adherence to aerobic and resistance physical activity guidelines among cancer prevention patients and survivors.
    Coletta AM; Marquez G; Thomas P; Thoman W; Bevers T; Brewster AM; Hawk E; Basen-Engquist K; Gilchrist SC
    PLoS One; 2019; 14(8):e0220814. PubMed ID: 31369653
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cognitive function of older patients receiving adjuvant chemotherapy for breast cancer: a pilot prospective longitudinal study.
    Hurria A; Rosen C; Hudis C; Zuckerman E; Panageas KS; Lachs MS; Witmer M; van Gorp WG; Fornier M; D'Andrea G; Moasser M; Dang C; Van Poznak C; Hurria A; Holland J
    J Am Geriatr Soc; 2006 Jun; 54(6):925-31. PubMed ID: 16776787
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.